Loading clinical trials...
Loading clinical trials...
Prevalence of Infection and Seroconversion and the Clinical Course of the Novel Coronavirus SARS-CoV-2 Infection in Children Between 0 to 18 Years of Age in Hamburg and Surroundings
Conditions
Locations
1
Germany
Universitätsklinikum Hamburg-Eppendorf
Hamburg, Germany
Start Date
May 11, 2020
Primary Completion Date
June 30, 2020
Completion Date
March 31, 2021
Last Updated
September 1, 2020
NCT06631287
NCT05141058
NCT06679140
NCT06160128
NCT07300839
NCT04392401
Lead Sponsor
Universitätsklinikum Hamburg-Eppendorf
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions